跳至主要内容
临床试验/JPRN-UMIN000047275
JPRN-UMIN000047275招募中未知

Analysis of the Listing's plane during Coriolis and visual stimulations - Analysis of the Listing's plane during Coriolis and visual stimulations

Department of Otorhinolaryngology Tokyo Medical and Dental University0 个研究点目标入组 30 人开始时间: 2022年4月1日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • vertiginous disease and deficit of ocular movement

研究者

发起方
Department of Otorhinolaryngology Tokyo Medical and Dental University

相似试验

已完成
Unknown
Outcome of Clareon Toric Intraocular Lens Implantation in Cataract PatientsEye - Diseases / disorders of the eyeCataract
ACTRN12624000221550Ben LaHood161
招募中
不适用
A Prospective Registry Study to Evaluate the Effect of the DCISionRT Test on Treatment Decisions in Patients with Ductal Carcinoma In Situ (DCIS) Following Breast Conserving Therapy to Determine the Clinical Utility of the DCISionRT Test in the Management of DCISDuctal carcinoma in situ (DCIS) of the breastCancer - Breast
ACTRN12621000695808Prelude Australia Pty Limited1,500
进行中(未招募)
1 期
A phase II open label, roll over study of the long term tolerability, safety and efficacy of oral BIBF 1120 in patients with Idiopathic Pulmonary FibrosisMedDRA version: 17.0Level: PTClassification code 10021240Term: Idiopathic pulmonary fibrosisSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersIdiopathic Pulmonary Fibrosis
EUCTR2009-013788-21-HUBoehringer Ingelheim RCV GmBH & Co KG300
进行中(未招募)
1 期
A phase II open label, roll over study of the long term tolerability,safety and efficacy of oral BIBF 1120 in patients with IdiopathicPulmonary FibrosisMedDRA version: 17.0Level: PTClassification code 10021240Term: Idiopathic pulmonary fibrosisSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersIdiopathic Pulmonary Fibrosis
EUCTR2009-013788-21-BESCS Boehringer Ingelheim Comm.V300
进行中(未招募)
不适用
A phase II open label, roll over study of the long term tolerability,safety and efficacy of oral BIBF 1120 in patients with IdiopathicPulmonary FibrosisIdiopathic Pulmonary Fibrosis
EUCTR2009-013788-21-BGBoehringer Ingelheim RCV GmBH & Co KG300